𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation

✍ Scribed by Tatiana Witjas; Christelle Baunez; Jean Marc Henry; Marie Delfini; Jean Regis; André Ali Cherif; Jean Claude Peragut; Jean Philippe Azulay


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
60 KB
Volume
20
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

In Parkinson's disease, dopamine dysregulation syndrome (DDS) is characterized by severe dopamine addiction and behavioral disorders such as manic psychosis, hypersexuality, pathological gambling, and mood swings. Here, we describe the case of 2 young parkinsonian patients suffering from disabling motor fluctuations and dyskinesia associated with severe DDS. In addition to alleviating the motor disability in both patients, subthalamic nucleus (STN) deep brain stimulation greatly reduced the behavioral disorders as well as completely abolished the addiction to dopaminergic treatment. Dopaminergic addiction in patients with Parkinson's disease, therefore, does not constitute an obstacle to high‐frequency STN stimulation, and this treatment may even cure the addiction. © 2005 Movement Disorder Society


📜 SIMILAR VOLUMES


Subthalamic nucleus deep brain stimulati
✍ Michelle R. Ciucci; Julie M. Barkmeier-Kraemer; Scott J. Sherman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

## Abstract Relatively little is known about the role of the basal ganglia in human deglutition. Deep brain stimulation (DBS) affords us a model for examining deglutition in humans with known impairment of the basal ganglia. The purpose of this study was to examine the effects of subthalamic nuclei

Functional imaging of subthalamic nucleu
✍ Tessel Boertien; Ludvic Zrinzo; Joshua Kahan; Marjan Jahanshahi; Marwan Hariz; L 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

Deep brain stimulation of the subthalamic nucleus is an accepted treatment for the motor complications of Parkinson's disease. The therapeutic mechanism of action remains incompletely understood. Although the results of deep brain stimulation are similar to the results that can be obtained by lesion

Subthalamic nucleus deep brain stimulati
✍ Wataru Sako; Masami Nishio; Tomoyuki Maruo; Hideki Shimazu; Kazuhito Matsuzaki; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB

## Abstract Camptocormia becomes increasingly recognized as a disabling symptom associated with Parkinson's disease (PD). We here report six patients with advanced PD in whom continuous bilateral stimulation of the subthalamic nucleus produced substantial (mean 78% ± 9.1% of the thoracolumbar angle

Contrast sensitivity in Parkinson's dise
✍ Kelvin L. Chou; Melissa M. Amick; Margaret Gagner 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 1 views

## Abstract This study examined whether deep brain stimulation (DBS) would affect the contrast sensitivity (CS) curve in patients with PD. CS was tested in 12 nondemented PD patients treated with bilateral subthalamic nucleus DBS on and off stimulation and medications. Neither stimulation condition

Treatment of dysarthria following subtha
✍ Elina Tripoliti; Laura Strong; Freya Hickey; Tom Foltynie; Ludvic Zrinzo; Joseph 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

## Abstract ## Background: Deep brain stimulation of the subthalamic nucleus (STN‐DBS) is an established treatment for patients with Parkinson's disease (PD). Speech impairment is a frequent side effect of the surgery. This study examined the efficacy of an intensive speech treatment, the Lee Silv